Evidence map›Paper›PMID 42199010›Full record

ReviewJournal of microbiology and biotechnology2026

Modulation of Host Innate Immune Response by Highly Pathogenic Human Coronaviruses during Viral Infection.

Yu-Jin Kim, Su Jin Lee, Wooseong Lee, Seong-Jun Kim, Dae-Gyun Ahn

Abstract readReview
In one paragraph

Review in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu-Jin KimCenter for Infectious Disease Vaccine and Diagnosis Innovation, Therapeutics and Biotechnology division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
Su Jin LeeCenter for Infectious Disease Vaccine and Diagnosis Innovation, Therapeutics and Biotechnology division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
Wooseong LeeUntreatable Infectious Disease Institute, Kyungpook National University, Daegu 41944, Republic of Korea.
Seong-Jun KimDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Dae-Gyun AhnCenter for Infectious Disease Vaccine and Diagnosis Innovation, Therapeutics and Biotechnology division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highly pathogenic human coronaviruses, including SARS-CoV, SARS-CoV-2, and MERS-CoV have emerged as significant public health threats due to their ability to cause widespread outbreaks and pandemics. These viruses induce dysregulated inflammatory responses, typified by cytokine storms that drive extensive tissue damage in pulmonary and extrapulmonary systems, leading to acute respiratory distress syndrome (ARDS) and multi-organ failure. These pathological outcomes are driven by sophisticated mechanisms that manipulate host immune pathways and evade innate and adaptive immune surveillance. The innate immune system plays a pivotal role in the early detection and control of viral infections through mechanisms such as cytoplasmic RNA sensors, Toll-like receptors, interferon signaling, and inflammasome activation. However, these coronaviruses effectively exploit and subvert these processes, suppressing antiviral defenses while amplifying inflammatory cascades. This review delineates the molecular and cellular strategies employed by these pathogens to evade immune recognition and exacerbate immune-mediated tissue injury. Understanding these processes is fundamental for guiding the development of targeted antiviral interventions, immunomodulatory therapeutics, and robust strategies to mitigate the impact of future coronavirus pandemics.

Indexed as

CoronavirusImmunity, InnateAnimalsCOVID-19Host-Pathogen InteractionsHumansImmune EvasionInnate Immunity RecognitionMiddle East Respiratory Syndrome CoronavirusPandemicsSARS-CoV-2Severe acute respiratory syndrome-related coronavirusCoronavirusCOVID-19Immune evasionImmune modulationInnate immunity

Identifiers

PMID42199010
PMCPMC13215871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.